Marco Chiumente

Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Venues

Cancers

Hematology reports

Journal of chemotherapy (Florence, Italy)

Immunotherapy

SIFaCT - Società Italiana di Farmacia Clinica e Terapia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SIFaCT - Società Italiana di Farmacia Clinica e Terapia Mar 01 2015

Italy

Scientific coordinator

Publications

Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Alberto Russi, Elena Svegliati, Paolo Baldo, Sabrina Orzetti, Fiorenza Enrico, Federico Foglio, Davide Pinnavaia, Vito Ladisa, Claudia Lauria Pantano, Rosa Lerose, Patrizia Nardulli, Simona Ferraiuolo, Piera Maiolino, Immacolata De Stasio, Federica Gradellini, Anna Rita Gasbarro, Rossella Santeramo, Gisella Carrucciu, Riccardo Provasi, Mario Cirino, Paola Cristina Cappelletto, Elisabetta Fonzi, Alessandra Pasqualini, Stefano Vecchia, Marianna Veraldi, Adele Emanuela De Francesco, Lucio Crinò, Angelo Delmonte, Carla Masini
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (" PEMBROREAL " Study). Cancers 16 (10) (2024)
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Alberto Russi, Elena Svegliati, Paolo Baldo, Sabrina Orzetti, Fiorenza Enrico, Federico Foglio, Davide Pinnavaia, Vito Ladisa, Claudia Lauria Pantano, Rosa Lerose, Patrizia Nardulli, Simona Ferraiuolo, Piera Maiolino, Immacolata De Stasio, Federica Gradellini, Anna Rita Gasbarro, Rossella Santeramo, Gisella Carrucciu, Riccardo Provasi, Mario Cirino, Paola Cristina Cappelletto, Elisabetta Fonzi, Alessandra Pasqualini, Stefano Vecchia, Marianna Veraldi, Adele Emanuela De Francesco, Lucio Crinò, Angelo Delmonte, Carla Masini
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (" PEMBROREAL " Study). Cancers 16 (10) (2024)
Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Andrea Ossato, Daniele Mengato, Marco Chiumente, Andrea Messori, Vera Damuzzo
Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens. Cancers 15 (7) (2023)
Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Melania Rivano, Daniele Mengato, Marco Chiumente, Andrea Messori
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons. Hematology reports 15 (4) (2023)
Daniele Mengato, Luca Cancanelli, Melania Rivano, Marco Chiumente, Lorenzo Di Spazio, Andrea Messori
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer. Immunotherapy 14 (11) (2022)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Daniele Mengato, Marco Chiumente, Andrea Messori
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials. World journal of urology 40 (11) (2022)
Andrea Ossato, Vera Damuzzo, Paolo Baldo, Daniele Mengato, Marco Chiumente, Andrea Messori
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data. Cancer medicine (2022)
Vera Damuzzo, Laura Agnoletto, Roberta Rampazzo, Francesca Cammalleri, Luca Cancanelli, Marco Chiumente, Stefano Costantino, Silvia Michielan, Federica Milani, Alessia Sartori, Melania Rivano, Daniele Mengato
The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis. Neurology international 13 (4) (2021)
Andrea Messori, Melania Rivano, Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente
A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia. Leukemia & lymphoma 63 (5) (2021)
Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo
Hospital Pharmacy Response to Covid-19 Pandemic in Italy: What We Learned From the First Outbreak Wave. Journal of pharmacy practice (2021)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies. Immunotherapy 13 (2) (2020)
Melania Rivano, Luca Cancanelli, Andrea Zovi, Chiara Addis, Daniele Mengato, Marco Chiumente, Andrea Messori
Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression. Journal of chemotherapy (Florence, Italy) 32 (5) (2020)
Alberto Russi, Vera Damuzzo, Marco Chiumente, Jacopo Pigozzo, Marco Cesca, Vanna Chiarion Sileni, Angelo Claudio Palozzo
Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study. Journal of chemotherapy (Florence, Italy) 29 (4) (2017)
Debjani Mueller, Iñaki Gutiérrez-Ibarluzea, Tara Schuller, Marco Chiumente, Jeonghoon Ahn, Andres Pichon-Riviere, Sebastian García-Martí, David Grainger, Elizabeth Cobbs, Marco Marchetti
CAPACITY BUILDING IN AGENCIES FOR EFFICIENT AND EFFECTIVE HEALTH TECHNOLOGY ASSESSMENT. International journal of technology assessment in health care 32 (4) (2016)

Marco Chiumente.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Chiumente